Riskpilot← Back to searchSign inGet full accessSubcuject ApS
APSBankruptCVR 38349279Axeltorv 2Research and experimental development on natural sciences and engineering · NACE 7210Est. 20172 employees
Revenue 2022
DKK 2,6M
-157% vs 2021
EBITDA margin
5.8%
+102% vs 2021
Equity ratio
-115.1%
Financial strength
Net profit 2022
DKK -274K
+95% vs 2021
| Revenue | DKK 2,6M | -157% |
| EBITDA | DKK 149K | +102% |
| Net profit | DKK -274K | +95% |
| Total assets | DKK 3,8M | +35% |
| Equity | DKK -4,4M | -7% |
| Employees | 2 | — |
Legal name
Subcuject ApS
CVR number
38349279
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
19. januar 2017
Share capital
DKK 227.207
Employees
2 (FTE)
VAT registered
No
Audit selected
Yes
Last report
2022-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsens formand i forening med den administrerende direktør eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at udvikle og sælge medicinsk udstyr, herunder at udvikle en mekanisk engangspumpe til levering af biologiske lægemidler samt aktiviteter i tilknytning hertil.
Address
Axeltorv 2
Email
claus.s.moeller@c-p-u.dk
- Event
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Revenue | -2.702 | -2.230 | -3.178 | -2.732 | -4.491 | 2.554 |
| Staff expenses | -1.368 | -2.135 | -2.142 | -2.192 | -2.386 | -2.405 |
| EBITDA | -4.070 | -4.364 | -5.320 | -4.924 | -6.877 | 149 |
| Depreciation & amort. | -0 | -3 | -7 | -7 | -4 | -0 |
| EBIT | -4.070 | -4.367 | -5.327 | -4.931 | -6.881 | 149 |
| Net financials | -100 | -90 | -16 | -77 | -323 | -500 |
| Profit before tax | -4.170 | -4.457 | -5.343 | -5.008 | -7.204 | -352 |
| Tax | -741 | -642 | -1.165 | -971 | -1.191 | -77 |
| Net profit | -3.429 | -3.815 | -4.178 | -4.038 | -6.013 | -274 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Total assets | 5.061 | 1.885 | 4.136 | 9.784 | 2.793 | 3.784 |
| Equity | 3.749 | 334 | 3.710 | 1.931 | -4.082 | -4.357 |
| Long-term debt | 1.030 | 1.112 | 0 | 5.940 | 6.216 | 6.520 |
| Short-term debt | 282 | 439 | 426 | 1.913 | 659 | 1.620 |
| Total debt | 1.312 | 1.551 | 426 | 7.853 | 6.875 | 8.140 |
EBITDA margin
5.8%
This company
15.8%
Market median
-63% vs market
20172022
Equity ratio
-115.1%
This company
38.2%
Market median
-401% vs market
20172022
Return on equity
-27417200.0%
This company
18.4%
Market median
-149006622% vs market
20172022
Net profit margin
-10.7%
This company
8.1%
Market median
-232% vs market
20172022
Asset turnover
0.67×
This company
1.12×
Market median
-40% vs market
20172022
Debt / equity
1.87×
This company
0.62×
Market median
-202% vs market
20172022
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-02 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JR Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
TK Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2019 | — | — | |
| Chairman | 2017 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Danmarks Eksport- og Investeringsfond | Company | 33.3% | 33.3% | 2023 |
C. S. Møller ApS | Company | 33.3% | 33.3% | 2023 |
ROESTED PARTNERS ApS | Company | 20.0% | 20.0% | 2023 |
Styrelsen for Forskning og Uddannelse | Company | 20.0% | 20.0% | 2017 |
VÆKSTFONDEN | Company | 33.3% | 33.3% | 2019 |
Uddannelses- og Forskningsstyrelsen | Company | 15.0% | 15.0% | 2020 |
| Individual | 100.0% | 100.0% | 2017 | |
CLAUS DEMANT ApS | Company | 5.0% | 5.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ROESTED PARTNERS ApS
Subcuject ApS Board members of Subcuject ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jesper Roested | Chief Executive Officer | 0 companies |
| Troels Keldmann | Chief Executive Officer | 0 companies |
| Lars Henning Stigel | Board of Directors | 0 companies |
| Anders Holme Jensen | Board of Directors | 0 companies |
| Claus Demant | Board of Directors | 0 companies |
| Otto Bjerg Hausgaard | Board of Directors | 0 companies |
| Charlotte Bruun Piester | Board of Directors | 0 companies |
| Tonni Bülow-Nielsen | Board of Directors | 0 companies |
| Paul Edward Jansen | Board of Directors | 0 companies |
| Morten Nielsen | Board of Directors | 0 companies |
| Lars Guldbæk Karlsen | Chairman | 0 companies |